Ceftriaxone Injectable Antibiotic Recalled Nationwide for Sterility Assurance Deficiency
Astral SteriTech's 66,125-vial ceftriaxone injection is being recalled nationwide due to lack of assurance of sterility in manufacturing. The product is distributed across the United States.
- Product
- Ceftriaxone for Injection, USP 250 mg per vial, Rx only, Manufactured for: Xellia Pharmaceuticals USA, LLC, Buffalo Grove, IL 60089, NDC 70594-094-02
- Category
- Drug
- Distribution
- Distributed nationwide